Stocktoria

IMMUNIC, INC. IMUX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-04-17 · LEI

IMMUNIC, INC. statistics & valuation

Market cap$208.4M

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-70.10% -59.90% -27.70% -73.10% -105.90% -323.60% -545.40% 2016201720182019202020212022202320242025
Shares outstanding
32.1M 42.4M 846953 10.7M 21.2M 26.3M 39.3M 45.2M 100.2M 155.7M 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-64.00% -86.20% -86.30% -53.00% -26.20% -66.80% -94.20% -172.40% -245.90% -404.00% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$2.81 -$3.93 -$3.78 -$2.11 -$1.00 -$0.62 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-404.0%-245.9%-172.4%-94.2%-66.8%-26.2%-53.0%-86.3%-86.2%-64.0%
Return on equity1456.2%-545.4%-323.6%-105.9%-73.1%-27.7%-59.9%44.8%390.5%-70.1%
Current ratio0.751.772.129.629.2115.934.566.945.6511.22

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.